Drug Pipeline & Clinical Trial Success: Positive clinical trial results and new drug approvals typically drive PFE.DU stock price up, while failures can cause declines.

Regulatory Decisions & Approvals: FDA and other regulatory body decisions concerning drug approvals, safety warnings, or market exclusivity greatly influence investor sentiment and stock value.

Competition: The emergence of competing drugs or biosimilars can erode Pfizer's market share and profitability, negatively impacting the stock price.

Patent Expirations: When patents expire, generic versions can enter the market, reducing Pfizer's revenue from those drugs and potentially lowering the stock price.

Overall Market Conditions: Broad economic trends, interest rates, and investor confidence in the pharmaceutical sector can affect PFE.DU, even without company-specific news.

Financial Performance: Revenue, earnings, profit margins, and future growth prospects as reported in financial statements significantly impact investor perceptions and stock price movements.

Mergers & Acquisitions: Announcements of potential or completed mergers, acquisitions, or divestitures can create volatility and influence the stock price.

Dividend Yield & Payout Ratio: A high dividend yield can attract income-seeking investors and support the stock price, but changes in dividend policy can have an opposite effect.

Global Health Events: Pandemics or major disease outbreaks can create demand for Pfizer's products, temporarily or permanently altering its stock value.

Political & Legal Environment: Government regulations, drug pricing policies, and potential lawsuits or legal challenges can affect Pfizer's profitability and stock valuation.